Paclitaxel-coated balloon plus EPC stent | EPC stent alone | p Value | |
No. of patients | 62 | 58 | |
Age (years) | 66.3±14.4 | 63.3±17.9 | 0.43 |
Male sex | 44 (71.0%) | 37 (63.8%) | 0.40 |
Cardiac risk factor | |||
Diabetes mellitus | 16 (25.8%) | 15 (25.9%) | 0.99 |
Arterial hypertension | 53 (85.5%) | 53 (91.4%) | 0.31 |
Hyperlipidaemia | 37 (59.7%) | 36 (62.1%) | 0.79 |
History of smoking | 26 (41.9%) | 26 (44.8%) | 0.75 |
Renal insufficiency | 9 (14.5%) | 3 (5.2%) | 0.13 |
Body mass index (kg/m2) | 28.6±4.0 | 28.5±4.1 | 0.89 |
Prior bypass surgery | 3 (4.8%) | 2 (3.4%) | 1.0 |
Clinical characteristic | |||
Stable angina | 47 (75.8%) | 42 (72.4%) | 0.67 |
Unstable angina | 15 (24.2%) | 16 (27.6%) | 0.67 |
Target-vessel location | |||
Left anterior descending artery | 15 (24.2%) | 21 (36.2%) | 0.15 |
Left circumflex artery | 20 (32.3%) | 12 (20.7%) | 0.15 |
Right coronary artery | 27 (43.6%) | 25 (43.1%) | 0.96 |
EPC, endothelial progenitor cell capturing.